An artificial intelligence optimized hepatic differentiation unveils NR5A2 and AP-1 transcriptional regulation in hepatic maturation

Read full text
Authors: Zijun Huo, Jian Feng Tu, Wei‐Lei Yang, Mo-Fan Huang, Ruoyu Wang, Chih-Wei Chu, An Xu, Yao Yu, Tara N. Tavakol, Mikal Kizilbash, Megan E Fisher, Yu-Wen Huang
+11 more Dandan Zhu, Trinh T. T. Phan, Rachel Shoemaker, Ya‐Wen Chen, Yang Zhang, Chad D. Huff, Shih-Yu Chen, Tien-Jen Liu, Haipeng Xiao, Dung‐Fang Lee, Ruiying Zhao
Cited by: 1
References: 66

Abstract

The generation of hepatocyte-like cells (HLCs) from human pluripotent stem cells (hPSCs) holds great promise for drug discovery and cell-based therapy for liver disease. However, current differentiation protocols are complicated and unstable, and the underlying gene regulatory mechanisms of hepatic differentiation remain incompletely defined. Here, we developed a machine learning-based artificial intelligence (AI) tool using phase-contrast images of hepatic progenitor cells (HPCs), which are essential for generating HLCs. The AI tool significantly improves the success rate of hepatic differentiation without the need for immunostaining or lineage tracing. By optimizing the methodology, we achieved an impressive purity of 90 to 95% for HLCs derived from hPSCs, aided by the AI algorithm. Through further investigating transcriptomes and epigenomic changes, we discovered the pivotal roles of nuclear receptor subfamily 5 group A member 2 and activator protein-1 transcription factors in regulating the maturation of hepatocytes. Single-cell RNA sequencing demonstrated the upregulation of nuclear receptor subfamily 5 group A member 2 and activator protein-1 during hepatic differentiation. Importantly, mutation analysis and tumorigenesis assays confirmed the safety of this modified hepatic differentiation protocol. This work highlights the potential of combining AI algorithm and computational genomics to facilitate development of lineage differentiation and molecular mechanism study.

Fields of Study & Subjects

Liver physiology and pathology Pluripotent Stem Cells Research Cholesterol and Lipid Metabolism

Publication details

Journal / source
Journal of Biological Chemistry
Publisher
Elsevier BV
Volume
302
Issue
6
Pages
111435–111435
Publication date
8 April 2026
Language
EN